Source:http://linkedlifedata.com/resource/pubmed/id/13720720
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1961-12-1
|
pubmed:keyword | |
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0393-3660
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
120
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
146-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
1961
|
pubmed:articleTitle |
[Clinical experience with N-(5-nitro-2-furfurylidene)3-amino-2-oxazolidone].
|
pubmed:publicationType |
Journal Article
|